2025-2026 Regular Session • Minnesota Legislature
HF1379
Legislative Summary
Use of nonopioid directives authorized, and immunity for certain acts or failures to act established.
Demographic Impact
Overall analysis of equity impact
90% Positive
High ConfidenceView detailed demographic breakdown ↓Unlock Full Demographic Insights
Go beyond the overall score.
Gain a deeper understanding of this bill's potential impact across diverse communities, including detailed breakdowns by category and subgroup. Access to this granular analysis helps ensure equitable outcomes.
Enable full analysis features for your organization.
Contact Sales to Learn MoreOr email us directly at sales@legiequity.us.
Bill History
2/24/2025
Introduction and first reading, referred to Health Finance and Policy
House of Representatives
2/26/2025
Author added Virnig
House of Representatives
3/5/2025
Author added Backer
House of Representatives
3/11/2025
Authors added Elkins, Bahner, and Perryman
House of Representatives
3/13/2025
Committee report, to adopt as amended and re-refer to Judiciary Finance and Civil Law
House of Representatives
3/27/2025
Committee report, to adopt as amended and re-refer to Health Finance and Policy
House of Representatives
Status Information
Current Status
Introduced(2/24/2025)
Chamber
House of Representatives
Committee
Health Finance & Policy(House of Representatives)
Sponsors
Republican: 4
Democrat: 4
Primary Sponsor
Dave Baker
Republican